Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients: a Spanish Multicenter, Randomized, Controlled Parallel-group Trial: The TRAINING Study

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Antithymocyte globulin (Primary) ; Mycophenolate; Prednisone; Steroids; Tacrolimus
Indications Renal transplant rejection
Focus Therapeutic Use
Acronyms TRAINING study

24 Nov 2023 Planned End Date changed from 1 Dec 2024 to 30 Jun 2024.
24 Nov 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
14 Mar 2022 Status changed to recruiting, according to European Clinical Trials Database

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com